Nitrosamines RA evaluation deadline extended due to coronavirus spreading
European Medicines Regulatory Network agreed to proceed with the extension of the Step 1 (risk evaluation) deadline to October 1st, 2020, due to Covid-19 spreading.
Tag: hma
Nitrosamine – Risk Evaluation: new deadlines for BIO and Chemical products announced
Nitrosamine Risk Assessment (Step 1): new deadlines for BIO and Chemical products […]